Software as a Medical Device (SaMD) Registration in the European Union (EU) Market

Bringing Software as a Medical Device (SaMD) to the European Union requires compliance with the EU Medical Device Regulation (MDR) 2017/745 and the In Vitro Diagnostic Regulation (IVDR) 2017/746. Masuu Global Solutions supports manufacturers through every phase of compliance, CE marking, and market entry, ensuring that your digital health innovation meets EU expectations for safety, performance, and reliability.

Overview

The European SaMD landscape is expanding rapidly due to increased adoption of remote health technologies, AI-driven diagnostics, and software based clinical tools. In the EU, the term “Software as a Medical Device (SaMD)” is not used formally—instead, such products are regulated as Medical Device Software (MDSW) under MDR and IVDR.

These regulations establish strict criteria for software design, development, validation, cybersecurity, clinical evidence, and post market obligations.

Performance Evaluation – Market Context

The global surge in digital health has accelerated demand for independent medical software, including decision support tools, diagnostic applications, and virtual monitoring platforms. The EU market continues to grow as healthcare shifts toward interoperable systems and data driven care delivery.

MDR/IVDR ensures that such software meets rigorous safety, performance, and clinical evidence requirements before it reaches patients or clinicians.

How Does Software Qualify as a Medical Device in the EU?

To determine whether your software qualifies as Medical Device Software under EU rules, consider the following:
Your software may qualify as SaMD/MDSW if:
  • It is intended to perform one or more medical functions, such as diagnosis, monitoring, prediction, or treatment.
  • It executes these functions independently of hardware.
Your software may NOT be considered standalone SaMD if:
  • It controls, drives, or influences a hardware medical device (this is classified as SiMD — Software in a Medical Device).
  • Its functions are not related to medical purposes as defined by MDR/IVDR.

Masuu Global Solutions helps you determine qualification, classification, and the correct regulatory pathway.

How to Register Your SaMD in the EU (MDR/IVDR Pathway)

Bringing SaMD to the EU market involves several structured steps:

Determine Qualification and Classification

  • Classification follows MDR rules (particularly Rule 11), based on the risk to patients and users.
  • Higher risk software classes typically require involvement of a Notified Body (NB).

Conduct a Conformity Assessment

Depending on risk class, this may include:
  • Review of Quality Management System (QMS) under ISO 13485
  • Examination of software lifecycle documentation (IEC 62304)
  • Cybersecurity (IEC 81001 5 1 / MDCG guidance)
  • Clinical evaluation requirements
  • Risk management (ISO 14971)

Prepare Technical Documentation

This includes:
  • Software design and architecture
  • Verification and validation reports
  • Clinical evidence
  • Usability engineering
  • Cybersecurity controls
  • Post market surveillance plans

Achieve CE Marking

Once the Notified Body approves the conformity assessment (for applicable classes), the manufacturer may affix the CE mark.

Register in EUDAMED

Manufacturers, authorized representatives, and the device itself must be registered in the European Database on Medical Devices.

Maintain Post Market Requirements

Post market surveillance, vigilance, PMS reporting, and periodic updates are mandatory to maintain EU compliance.

Masuu Global Solutions provides full lifecycle support—including documentation, CE marking preparation, NB coordination, and PMS guidance.

Masuu Global Solutions – SaMD Registration Support for Europe, Australia & Korea

Expertise

  • Tailored MDR/IVDR regulatory strategy for SaMD
  • In depth market and regulatory intelligence
  • SaMD classification and registration services
  • Support throughout product development documentation
  • Guidance for clinical evaluation and performance studies
  • Post approval lifecycle management
  • EU / UK / Switzerland authorized representative services

Advantages

  • Proven success supporting SaMD approvals across various classes
  • Skilled regulatory experts dedicated to MDR/IVDR compliance
  • Timely and predictable submission processes
  • Local partners to address HA requirements and language needs
  • Cost effective in country representation options
  • Flexible regulatory staffing and resource augmentation
Book a Demo